Pulmonary and Renal Responses to Furosemide in Infants With Stage III-IV Bronchopulmonary Dysplasia

Hemendra Patel, Tsu Fuh Yeh, Renu Jain, Rosita Pildes

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Pulmonary and renal responses to furosemide were evaluated in ten infants with stage III-IV bronchopulmonary dysplasia. Furosemide was given intravenously for two doses, 1 and 2 mg/kg, at approximately 24-hour intervals. The following indices were evaluated in series before and after entry Into study: clinical respiratory distress syndrome score; blood pH; partial pressure of arterial carbon dioxide; alveolar-arterial oxygen gradient; urine output; glomerular filtration rate; fractional excretion of filtered sodium, chloride, potassium, and calcium; osmolar clearance; water clearance; and concentrations of serum electrolytes and calcium. A significant decrease in the respiratory distress syndrome score and in the partial pressure of arterial carbon dioxide was seen only transiently at two hours following each dose. There was no significant improvement in the alveolar-arterial oxygen gradient during the study. Furosemide induced diuresis and urinary excretion of sodium, chloride, potassium, and calcium. A significant decrease in serum chloride and potassium concentrations was seen at 48 hours after entry intostudy; serum sodium and calcium concentrations remained unchanged. This study has demonstrated that furosemide administration has only a short-term effect in the lung but has a potential for long-term complication on electrolytes and calcium balance in infants with well-established stage III-IV bronchopulmonary dysplasia.

Original languageEnglish
Pages (from-to)917-919
Number of pages3
JournalAmerican Journal of Diseases of Children
Volume139
Issue number9
DOIs
Publication statusPublished - Jan 1 1985
Externally publishedYes

Fingerprint

Bronchopulmonary Dysplasia
Furosemide
Calcium
Kidney
Lung
Partial Pressure
Carbon Dioxide
Sodium Chloride
Potassium
Serum
Oxygen
Water-Electrolyte Balance
Potassium Chloride
Diuresis
Glomerular Filtration Rate
Electrolytes
Sodium
Urine
Water

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Pulmonary and Renal Responses to Furosemide in Infants With Stage III-IV Bronchopulmonary Dysplasia. / Patel, Hemendra; Yeh, Tsu Fuh; Jain, Renu; Pildes, Rosita.

In: American Journal of Diseases of Children, Vol. 139, No. 9, 01.01.1985, p. 917-919.

Research output: Contribution to journalArticle

@article{3663f49390484334b75c89f9ed5e395e,
title = "Pulmonary and Renal Responses to Furosemide in Infants With Stage III-IV Bronchopulmonary Dysplasia",
abstract = "Pulmonary and renal responses to furosemide were evaluated in ten infants with stage III-IV bronchopulmonary dysplasia. Furosemide was given intravenously for two doses, 1 and 2 mg/kg, at approximately 24-hour intervals. The following indices were evaluated in series before and after entry Into study: clinical respiratory distress syndrome score; blood pH; partial pressure of arterial carbon dioxide; alveolar-arterial oxygen gradient; urine output; glomerular filtration rate; fractional excretion of filtered sodium, chloride, potassium, and calcium; osmolar clearance; water clearance; and concentrations of serum electrolytes and calcium. A significant decrease in the respiratory distress syndrome score and in the partial pressure of arterial carbon dioxide was seen only transiently at two hours following each dose. There was no significant improvement in the alveolar-arterial oxygen gradient during the study. Furosemide induced diuresis and urinary excretion of sodium, chloride, potassium, and calcium. A significant decrease in serum chloride and potassium concentrations was seen at 48 hours after entry intostudy; serum sodium and calcium concentrations remained unchanged. This study has demonstrated that furosemide administration has only a short-term effect in the lung but has a potential for long-term complication on electrolytes and calcium balance in infants with well-established stage III-IV bronchopulmonary dysplasia.",
author = "Hemendra Patel and Yeh, {Tsu Fuh} and Renu Jain and Rosita Pildes",
year = "1985",
month = "1",
day = "1",
doi = "10.1001/archpedi.1985.02140110071032",
language = "English",
volume = "139",
pages = "917--919",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Pulmonary and Renal Responses to Furosemide in Infants With Stage III-IV Bronchopulmonary Dysplasia

AU - Patel, Hemendra

AU - Yeh, Tsu Fuh

AU - Jain, Renu

AU - Pildes, Rosita

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Pulmonary and renal responses to furosemide were evaluated in ten infants with stage III-IV bronchopulmonary dysplasia. Furosemide was given intravenously for two doses, 1 and 2 mg/kg, at approximately 24-hour intervals. The following indices were evaluated in series before and after entry Into study: clinical respiratory distress syndrome score; blood pH; partial pressure of arterial carbon dioxide; alveolar-arterial oxygen gradient; urine output; glomerular filtration rate; fractional excretion of filtered sodium, chloride, potassium, and calcium; osmolar clearance; water clearance; and concentrations of serum electrolytes and calcium. A significant decrease in the respiratory distress syndrome score and in the partial pressure of arterial carbon dioxide was seen only transiently at two hours following each dose. There was no significant improvement in the alveolar-arterial oxygen gradient during the study. Furosemide induced diuresis and urinary excretion of sodium, chloride, potassium, and calcium. A significant decrease in serum chloride and potassium concentrations was seen at 48 hours after entry intostudy; serum sodium and calcium concentrations remained unchanged. This study has demonstrated that furosemide administration has only a short-term effect in the lung but has a potential for long-term complication on electrolytes and calcium balance in infants with well-established stage III-IV bronchopulmonary dysplasia.

AB - Pulmonary and renal responses to furosemide were evaluated in ten infants with stage III-IV bronchopulmonary dysplasia. Furosemide was given intravenously for two doses, 1 and 2 mg/kg, at approximately 24-hour intervals. The following indices were evaluated in series before and after entry Into study: clinical respiratory distress syndrome score; blood pH; partial pressure of arterial carbon dioxide; alveolar-arterial oxygen gradient; urine output; glomerular filtration rate; fractional excretion of filtered sodium, chloride, potassium, and calcium; osmolar clearance; water clearance; and concentrations of serum electrolytes and calcium. A significant decrease in the respiratory distress syndrome score and in the partial pressure of arterial carbon dioxide was seen only transiently at two hours following each dose. There was no significant improvement in the alveolar-arterial oxygen gradient during the study. Furosemide induced diuresis and urinary excretion of sodium, chloride, potassium, and calcium. A significant decrease in serum chloride and potassium concentrations was seen at 48 hours after entry intostudy; serum sodium and calcium concentrations remained unchanged. This study has demonstrated that furosemide administration has only a short-term effect in the lung but has a potential for long-term complication on electrolytes and calcium balance in infants with well-established stage III-IV bronchopulmonary dysplasia.

UR - http://www.scopus.com/inward/record.url?scp=0021855129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021855129&partnerID=8YFLogxK

U2 - 10.1001/archpedi.1985.02140110071032

DO - 10.1001/archpedi.1985.02140110071032

M3 - Article

VL - 139

SP - 917

EP - 919

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 9

ER -